Rene Russo - 21 Oct 2021 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ Chris Frankenfield, attorney-in-fact for Rene Russo
Issuer symbol
XLO
Transactions as of
21 Oct 2021
Net transactions value
$0
Form type
4
Filing time
25 Oct 2021, 17:18:55 UTC
Previous filing
09 Aug 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +50,041 $0.000000 50,041 21 Oct 2021 Common Stock 50,041 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on October 21, 2021 and shall begin to vest on November 1, 2021 and continue to vest in equal monthly installments thereafter until October 1, 2025.